Insider · CIK 0001638380
Shane Ward
cooofficer
Files at CDTX (Cidara Therapeutics, Inc.). First filing Mar 13, 2025, latest Mar 13, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 1
$0 bought, $37k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 39Weak | Cidara Therapeutics, Inc. | $37k 1,664 shares | -10% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Common Stock | +25,000 | $0.00 | $0 | 39,674 | Apr 2, 2025 |
| Mar 31, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Employee Stock Option (right to buy)derivative | +50,000 | $0.00 | $0 | 50,000 | Apr 2, 2025 |
| Mar 11, 2025 | CDTX Cidara Therapeutics, Inc. | SOpen-market sale Common Stock | -1,664 | $21.96 | $37k | 14,674 | Mar 13, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.